Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
High efficacy and low toxicity of weekly docetaxel treated breast cancer
June 23rd, 2005
Scientists recommended weekly docetaxel treatment of metastatic breast cancer because of its high efficacy and low toxicity. "Docetaxel is one of the most effective antitumor agents currently available for the treatment of metastatic breast cancer (MBC). This Phase II multicenter study prospectively analyzed the efficacy and toxicity of docetaxel given on a weekly schedule as first-line treatment of metastatic breast cancer," scientists in Germany reported. "All patients received docetaxel, 35 mg/m2 weekly for 6 weeks, followed by 2 weeks of rest," explained J. Stemmler and colleagues, University of Munich. "Subsequent cycles (3 weeks of...
Source: Women's Health Weekly (2005-06-23)
|
